Upload
luciano-lopez
View
222
Download
3
Embed Size (px)
Citation preview
Anticorpi Anti Gliadina Deamidata:un nuovo utile marker per la malattia celiaca
Sergio AmarriUO Pediatria
Azienda Ospedaliera Reggio Emilia
Sintomi tipici di malattia celiaca• diarrea• vomito• distensione addominale• perdita di peso• pallore• anoressia• magrezza• edemi• irritabilità
Manifestazioni extraintestinali• Dermatite erpetiforme• Anemia sideropenica di ndd• Bassa statura• Ritardo puberale• Infertilità ed aborti ricorrenti• Alopecia areata• Stomatite aftosa• Ipoplasia smalto dentario• Ipertransaminasemia di ndd• Epilessia farmaco-resistente, atassia , polineurite• Osteoporosi• Miocardiopatia dilatativa• Artriti
Quadri clinici e malattie associate
• Tiroidite di Hashimoto• Diabete tipo I: 3 – 8 %• Sindrome Down: 5 – 12 %• Sindrome di Turner• Sindrome di Sjogren• Deficit IgA• Sclerosi multipla• Cirrosi biliare primitiva
FORMA CLASSICA DI MALATTIA CELIACA
CELIACHIA
Biopsia positiva
IgA sieriche + anti-tTG positiviAGA < 2 anni di vita
Sintomi di malassorbimento
Sensibilità e Specificità (Istologia)Gold Standard
Test (sierologia)
positivo negativo
positivo a b
negativo c d
Sensibilità = a/(a+c) Specificità = d/(b+d) Alta sensibilità = pochi falsi negativi (c)!
Alta specificità = pochi falsi positivi (b)!
Combinazioni marker celiachiaEMA-IgA AGA-IgA* AGA-IgG* Diagnosi
anti-tTG IgA anti-tTG IgG
+ + + quasi certa
+ - + probabile
+ + - Più probabile
+ - - Probabile
- + + Probabile
- + - meno probabile
- - + Improbabile (deficit IgA!)
* AGA < 2 anni di età. Anti-tTG positivi conferma EMA
Utilità marker celiachia • Anti-transglutaminasi IgA (il più utile)
– Limiti: deficit di IgA e primi due anni di vita
• EMA IgA (meno sensibile e più specifico della tTG si usa per conferma)– Limiti: costoso e legato all’interpretazione
dell’operatore
• Anti-transglutaminasi IgG (poco accurato)
• AGA IgA (utile sotto i due anni di vita)
• AGA IgG (di scarsa utilità)
DGP
Celiac Disease NEJM 2007; 357:1731-1743
Peter H.R. Green and Christophe Cellier
Lewis&Scott. Deamidated gliadin and tTG compared as screening for coeliac disease. Aliment Pharmacol 2010
IgA - DGP
IgA - tTG
Lewis&Scott. Deamidated gliadin and tTG compared as screening for coeliac disease. Aliment Pharmacol 2010
IgA - DGP IgA - tTG
Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay ELISA methods. Aliment Pharmacol 2008; 28: 805-13
Testκ-Statistics
Sensitivity (%) Specificity (%) Accuracy (%)
MIA ELISA† MIA ELISA† MIA ELISA†
DGP IgA 0.89 71.6* 75.0* 92.7 95.2 83.9* 86.8*
DGP IgG 0.86 66.3 65.2 96.8 98.4 83.8 84.3
TTG IgA 0.97 81.8* 79.3* 98.4 98.4 91.5* 90.5*
TTG IgG 0.48 13.0 28.3 100.0 96.8 63.0 67.6
Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay ELISA methods. Aliment Pharmacol 2008; 28: 805-13
Test κ-Statistics
Sensitivity (%) Specificity (%) Accuracy (%)
MIA ELISA MIA ELISA MIA ELISA
DGP IgA or IgG
0.87 77.8
78.3 90.2
94.4 85.0
87.5
TTG IgA or IgG
0.93 82.2
80.4 98.4
96.0 91.5
89.4
DGP IgA or TTG IgA
0.93 83.0
83.0 92.7
95.2 86.6
90.1
DGP IgG or TTG IgA
0.96 84.4
82.6 95.9
97.6 91.1
91.2
DGP IgA or IgG or TTG IgA
0.91 85.6
83.7 90.2
94.4 88.3
89.8
DGP IgA or IgG or TTG IgA or IgG
0.88 85.6
83.7 90.2
91.9 88.3
88.4
Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay ELISA methods. Aliment Pharmacol 2008; 28: 805-13
Test
Sensitivity (%) Specificity (%) Accuracy (%)
MIA ELISA MIA ELISA MIA ELISA
DGP IgA and IgG
0.90 60.0 61.4 99.2 99.2 82.7 83.5
TTG IgA and IgG
0.50 11.1 25.3 100.0 99.2 62.6 68.7
DGP IgA and TTG IgA
0.96 70.5 71.3 98.4 98.4 86.7 87.2
DGP IgG and TTG IgA
0.88 63.3 60.9 99.2 99.2 84.1 83.4
DGP IgA and IgG and TTG IgA
0.91 60.0 58.6 99.2 99.2 82.7 82.5
DGP IgA and IgG and TTG IgA and IgG
0.57 11.1 20.7 100.0 99.2 62.6 66.8
Volta et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis
J Clin Gastroenterol 2009
Volta et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis
J Clin Gastroenterol 2009
test SENSIBILITA’ SPECIFICITA’
IgA tTG 93,7% 96,6%
IgA EMA 91,6% 100%
IgA DGP 84,3% 79,8%
IgG DGP 82,3% 98,9%
Copyright ©2009 American Association for Clinical Chemistry
Basso, D. et al. Clin Chem 2009;55:150-157
Individual values of AGA IgA II, AGA IgG II, and tTG IgA measured in the sera of children with (CD) or without (CS) typical celiac disease duodenal histology
Basso, D. et al. Clin Chem 2009;55:150-157
Positive result Sensitivity Specificity PPV NPV
AGA IgA II and tTG IgA 80.7 100 100 80.4
AGA IgA II or tTG IgA 92.5 90.6 92.5 90.6
AGA IgG II and tTG IgA
77.6 99.2 99.2 77.8
AGA IgG II or tTG IgA
95.0 95.3 96.2 93.8
AGA IgA II and AGA IgG II and tTG IgA
72.0 100 100 73.8
AGA IgA II or AGA IgG II or tTG IgA
95.0 89.8 92.2 93.4
Copyright ©2009 American Association for Clinical Chemistry
Basso, D. et al. Clin Chem 2009;55:150-157
ROC curves of AGA IgA II, AGA IgG II, and tTG IgA in distinguishing celiac disease from control children without total IgA deficiency
Copyright ©2009 American Association for Clinical Chemistry
Basso, D. et al. Clin Chem 2009;55:150-157
Median values, interquartile range, and outliers of AGA IgA II, AGA IgG II, and tTG IgA of children with CD subdivided according to Marsh-Oberhuber classification
Sensitivity (%) of antibody tests at more than 99% specificity*
23
Antibodies Against Deamidated Gliadin as New and Accurate Biomarkers of Childhood Coeliac DiseaseJPGN 2009: 49;52-58
•
24
Antibodies Against Deamidated Gliadin as New and Accurate Biomarkers of Childhood Coeliac DiseaseJPGN 2009: 49;52-58
25
Serum and intestinal celiac disease-associated antibodies in children with celiac disease < 2 years of age JPGN 2010; 50:43-48
(Amarri & Volta)Pazienti celiaci sesso: 4 F, 3M
età: range 16 – 28 mesi
sintomi all’esordio: diarrea, addome globoso, ipotonia muscolare, calo ponderale, astenia, famigliarità (1)
vn DGP-AGA IgG <10 AU
EmA IgA <1:5
tTG IgA <16 AU
AGA IgA*
AGA IgG <10
Biopsia
DRG 19.3 1:160 118.0 3A-B IS 126.0 1:640 129.0 >100 >100 3B BC 118.9 1:160 144.8 4.49 >100 3A PR 8.8 Neg 3.8 49.7 81.5 1 MA 124.0 1:80 128.4 82.9 3B-C SM 130.6 1:320 125.2 3C PA 105.8 1:320 126.7 >100 >100 3C
*AGA IgA vn <10, borderline 8-15, positivo > 15
NOS ANA Neurone DRG Neg Neg CNS+ IS Neg Cito+ Neg BC R1 Neg Neg PR Neg Neg Neg MA R1 ANAs Neg SM R1 Cito+ Neg PA Neg Neg Neg
Controlli sesso: 3 F e 3 M
età: range 12 - 28 mesipatologie: neurologiche, polmonari, F-U soggetti
asintomatici per infezioni peri-natali
AGA IgA vn <10, borderline 8-15, positivo > 15
Tutti i marker di celiachia e altri auto-anticorpi negativi, solo un caso di AGA IgA borderline (6.8)
Adattato da Basso, D. et al. Clin Chem 2009;55:150-157
Sensitivity Specificity PPV NPV
≤ 2 anni
AGA IgA II 80.0 93.8 96.0 71.4
AGA IgG II 96.7 100 100 94.1
tTG IgA 90 100 100 84.2
Change in DGP antibodies and TGAA in children receiving GFD vs regular dietLiu, Edwin et al JPGN 2007
30
Top, In children treated with GFD, DGP antibody levels significantly decreased (most resolved); however, children receiving a regular diet had persistently high levels of DGP antibodies. Bottom, TGAA levels also decreased significantly with GFD treatment, compared with children receiving a regular diet; however, the majority of children treated with GFD remained TGAA positive.
31
Liu, Edwin et al JPGN 2007
Liu, Edwin et al JPGN 2007Representative graphs of children treated with GFD over time. Arrow indicates time of biopsy with confirmed celiac disease, and institution of GFD. Sometimes, rarely, and never indicate patient-reported frequency of dietary indiscretion. A, Example of persistently positive TGAA with resolution of DGP antibodies. B, Example of transiently positive TGAA while DGP remained negative at all time points. C, Example of persistently positive TGAA and DGP antibodies. D, Example of complete resolution of both TGAA and DGP antibodies.
32
Solid line = DGP antibody, dashed line = TGAA
Gliadina Deamidata (DGP)
• L’anticorpo di classe IgG (IgG DGP) è la vera novità
• In aggiunta alle tTG aumenta la nostra capacità diagnostica
• IgG DGP:– Può essere impiegato nei deficit di IgA– Può essere impiegato sotto i due anni di età– Permette una conferma diagnostica e aumenta
la specificità dei due test combinati• IgG DGP è un marcatore più tempestivo della
aderenza alla dieta aglutinata
Possibile variazione iter diagnostico sierologico
IgA tTG IgA tTG
IgA EMA
IgG tTG
IgA AGA IgG DGP
Adattato da Volta et al. Expert Rev Gastroenterol Hepatol 2010